Cargando…
Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix
OBJECTIVE: To explore the potential molecular mechanism of Pueraria Lobata Radix (RP) and Salviae Miltiorrhizae Radix (RS) in the treatment of type 2 diabetes mellitus (T2DM) based on network pharmacology and molecular docking. METHODS: The chemical constituents and core targets of RP and RS were se...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938769/ https://www.ncbi.nlm.nih.gov/pubmed/36820318 http://dx.doi.org/10.1155/2023/9150324 |
_version_ | 1784890705708056576 |
---|---|
author | Mao, Jingxin Wang, Guowei Yang, Lin Tan, Lihong Tian, Cheng Tang, Lijing Fang, Ling Mu, Zhenqiang Zhu, Zhaojing Li, Yan |
author_facet | Mao, Jingxin Wang, Guowei Yang, Lin Tan, Lihong Tian, Cheng Tang, Lijing Fang, Ling Mu, Zhenqiang Zhu, Zhaojing Li, Yan |
author_sort | Mao, Jingxin |
collection | PubMed |
description | OBJECTIVE: To explore the potential molecular mechanism of Pueraria Lobata Radix (RP) and Salviae Miltiorrhizae Radix (RS) in the treatment of type 2 diabetes mellitus (T2DM) based on network pharmacology and molecular docking. METHODS: The chemical constituents and core targets of RP and RS were searched by Traditional Chinese Medicine System Pharmacology (TCMSP); target genes related to T2DM were obtained through GeneCards database, component target network diagram was constructed, intersection genes of active compounds and T2DM were synthesized, protein-protein interaction (PPI) relationship was obtained, and core targets were screened by using Cytoscape 3.7.2. Gene Ontology (GO) biological process and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were analyzed utilizing R studio 4.0.4 according to David database. Based on molecular docking, the screened active components of RP and RS were verified by molecular docking with the core target using Discovery Studio 2019. RESULTS: There were totally 92 components and 29 corresponding targets in the component target network of RP and RS drug pair, of which 6 were the core targets of RP and RS in the treatment of T2DM. Molecular docking results showed that the active compounds of puerarin, formononetin, tanshinone iia, and luteolin had better binding activity with AKT1, VEGFA, NOS3, PPARG, MMP9, and VCAM1, respectively. Among them, puerarin showed significant effects in activating NOS3 pathway and luteolin exhibited significant effects in activating MMP9 pathway, respectively. The main biological processes mainly including xenobiotic stimulus, response to peptide, gland development, response to radiation, cellular response to chemical stress, response to oxygen levels, and the main signal pathways include response to xenobiotic stimulus, cellular response to chemical stress, response to peptide, gland development, and response to oxygen levels. CONCLUSION: Network pharmacology is an effective tool to explain the action mechanism of Traditional Chinese Medicine (TCM) from the overall perspective. RP and RS pair could alleviate T2DM via the molecular mechanism predicted by the network pharmacology, which provided new ideas and further research on the molecular mechanism of T2DM. |
format | Online Article Text |
id | pubmed-9938769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99387692023-02-19 Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix Mao, Jingxin Wang, Guowei Yang, Lin Tan, Lihong Tian, Cheng Tang, Lijing Fang, Ling Mu, Zhenqiang Zhu, Zhaojing Li, Yan Comput Math Methods Med Research Article OBJECTIVE: To explore the potential molecular mechanism of Pueraria Lobata Radix (RP) and Salviae Miltiorrhizae Radix (RS) in the treatment of type 2 diabetes mellitus (T2DM) based on network pharmacology and molecular docking. METHODS: The chemical constituents and core targets of RP and RS were searched by Traditional Chinese Medicine System Pharmacology (TCMSP); target genes related to T2DM were obtained through GeneCards database, component target network diagram was constructed, intersection genes of active compounds and T2DM were synthesized, protein-protein interaction (PPI) relationship was obtained, and core targets were screened by using Cytoscape 3.7.2. Gene Ontology (GO) biological process and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were analyzed utilizing R studio 4.0.4 according to David database. Based on molecular docking, the screened active components of RP and RS were verified by molecular docking with the core target using Discovery Studio 2019. RESULTS: There were totally 92 components and 29 corresponding targets in the component target network of RP and RS drug pair, of which 6 were the core targets of RP and RS in the treatment of T2DM. Molecular docking results showed that the active compounds of puerarin, formononetin, tanshinone iia, and luteolin had better binding activity with AKT1, VEGFA, NOS3, PPARG, MMP9, and VCAM1, respectively. Among them, puerarin showed significant effects in activating NOS3 pathway and luteolin exhibited significant effects in activating MMP9 pathway, respectively. The main biological processes mainly including xenobiotic stimulus, response to peptide, gland development, response to radiation, cellular response to chemical stress, response to oxygen levels, and the main signal pathways include response to xenobiotic stimulus, cellular response to chemical stress, response to peptide, gland development, and response to oxygen levels. CONCLUSION: Network pharmacology is an effective tool to explain the action mechanism of Traditional Chinese Medicine (TCM) from the overall perspective. RP and RS pair could alleviate T2DM via the molecular mechanism predicted by the network pharmacology, which provided new ideas and further research on the molecular mechanism of T2DM. Hindawi 2023-02-11 /pmc/articles/PMC9938769/ /pubmed/36820318 http://dx.doi.org/10.1155/2023/9150324 Text en Copyright © 2023 Jingxin Mao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mao, Jingxin Wang, Guowei Yang, Lin Tan, Lihong Tian, Cheng Tang, Lijing Fang, Ling Mu, Zhenqiang Zhu, Zhaojing Li, Yan Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title_full | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title_fullStr | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title_full_unstemmed | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title_short | Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix |
title_sort | combined network pharmacology and molecular docking to verify the treatment of type 2 diabetes with pueraria lobata radix and salviae miltiorrhizae radix |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938769/ https://www.ncbi.nlm.nih.gov/pubmed/36820318 http://dx.doi.org/10.1155/2023/9150324 |
work_keys_str_mv | AT maojingxin combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT wangguowei combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT yanglin combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT tanlihong combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT tiancheng combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT tanglijing combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT fangling combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT muzhenqiang combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT zhuzhaojing combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix AT liyan combinednetworkpharmacologyandmoleculardockingtoverifythetreatmentoftype2diabeteswithpuerarialobataradixandsalviaemiltiorrhizaeradix |